It is time for a new comprehensive medication review quality measure

Melissa Castora-Binkley, Lisa Hines, Shannon Vaffis, Harman Dhatt, Elizabeth Anderson, Darlena Le, Heather Black, Patrick J. Campbell, Irina Kolobova, Mel Nelson, David R. Axon, Terri Warholak

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Medication therapy management (MTM) services include comprehensive medication reviews (CMRs), which have been completed with millions of patients since their inception in the United States. The current MTM quality measure focuses on whether CMRs were completed (ie, the CMR completion rate). However, this process measure does not assess quality of care, or patient-reported or other outcomes of CMRs, and, therefore, does not reward MTM providers for improving health outcomes. In this viewpoint article, we present 3 reasons that shape our argument for new MTM quality measures and offer recommendations on next steps to achieve this.

Original languageEnglish (US)
Pages (from-to)680-684
Number of pages5
JournalJournal of Managed Care and Specialty Pharmacy
Volume29
Issue number6
DOIs
StatePublished - Jun 2023

ASJC Scopus subject areas

  • Pharmacy
  • Pharmaceutical Science
  • Health Policy

Fingerprint

Dive into the research topics of 'It is time for a new comprehensive medication review quality measure'. Together they form a unique fingerprint.

Cite this